|

Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization

RECRUITINGSponsored by HemoCept Inc.
Actively Recruiting
SponsorHemoCept Inc.
Started2025-12-01
Est. completion2026-03-06
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT07224906

Summary

The objective of this observational pilot study is to collect HemoCept device data from subjects undergoing diagnostic right heart catheterization (RHC) procedures.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Subjects or representatives must have voluntarily signed the informed consent form before any study related procedures.
* Subjects can be any gender but must be age 18 or older.
* Subject is able and willing to provide informed consent and HIPAA authorization.
* Subject is able and willing to meet all study requirements.
* Scheduled for a diagnostic right heart catheterization (RHC-only or combined RHC+LHC; left-heart-only procedures are not eligible)

Exclusion Criteria:

* Subject is pregnant, breastfeeding, or intends to become pregnant during this study.

Conditions4

Congestive Heart Failure(CHF)Heart DiseasePulmonary HypertensionValve Disease, Heart

Locations1 site

Boulder Heart
Boulder, Colorado, 80303
Katharine Adkins303-442-2395kathari.adkins@bch.org

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.